We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Commentary · December 16, 2019

SGLT2 Inhibition for the Prevention of Diabetic Kidney Disease

Clinical journal of the American Society of Nephrology : CJASN


Additional Info

Disclosure statements are available on the authors' profiles:

Clinical journal of the American Society of Nephrology : CJASN
Sodium Glucose Cotransporter 2 Inhibition Heralds a Call-to-Action for Diabetic Kidney Disease
Clin J Am Soc Nephrol 2019 Nov 18;[EPub Ahead of Print], KR Tuttle, DZ Cherney

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading